Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2003
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162194 Diagnosis of diseases associated with apoptosis
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161884 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/28/2003US20030161883 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
08/28/2003US20030161842 Preferred mushroom source is Pleurotus eryngii (DC. et Fr.) Quel. obtained by solvent extraction including ethyl acetate; hypotensive agents and cardiovascular health; side effect reduction
08/28/2003US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161819 Genetic engineering; promoters; deactivation of major histocompatibility complex
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030159914 Plant extracts from fruit pits; presoaking in water, distillation; separation by specific gravity; bactericides, antiseptics; sterilization
08/28/2003CA2487395A1 Method for discovering pharmacologically active substances
08/28/2003CA2477205A1 Novel propionic acid derivative
08/28/2003CA2477117A1 Pyrrolopyrimidine derivative
08/28/2003CA2477014A1 Rna interference mediated inhibition of tnf and tnf receptor superfamily gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476837A1 Sodium channel blockers
08/28/2003CA2476832A1 Use of an inhibitor or antagonist against tissue factor
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476679A1 Vitamin d3 derivatives and remedies using the same
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2476115A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003CA2475879A1 Synthesis of quinazolinones
08/28/2003CA2475600A1 Method for producing high-quality hydrophobic licorice extract
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2419685A1 Antidiabetic agents
08/27/2003EP1338655A1 Substance inhibiting the binding of signal transducing molecule to kdr/flk-1 phosphorylated at tyrosine at the 1175-position and method of using the same
08/27/2003EP1338649A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof
08/27/2003EP1338604A1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres
08/27/2003EP1338600A1 Fused 1,2,4-Thiadiazine derivatives, their preparation and use
08/27/2003EP1338597A1 1,4,5,6-tetrahydroimidazo 4,5-d]diazepine derivatives or salts thereof
08/27/2003EP1338278A1 Administration of resveratrol to prevent or treat restenosis following coronary intervention
08/27/2003EP1338274A1 Process for preparing a particulate composition
08/27/2003EP1337633A2 Anti-angiogenic proteins and fragments and methods of use thereof
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337557A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337521A1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337508A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337272A2 Combination of gaba agonists and aldose reductase inhibitors
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1337243A2 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
08/27/2003EP1337242A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/27/2003EP1337238A1 Generation of therapeutic microfoam
08/27/2003EP1337218A2 Substituted felbamate derived compounds
08/27/2003EP1183047B1 Pharmaceutical preparation
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP1042368B1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
08/27/2003EP0906089B1 Buccal delivery system
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0891363B1 Heterocyclic compounds and their preparation and use
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003EP0739342B1 Pyridine modulators of acetylcholine receptors
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439012A 2-zminoalkyl-thieno [2,3-D] pyrimidines
08/27/2003CN1439011A 5-aminoalkyl-pyrazolo [4,3-d] pyrimidines with phosphodiesterase v-inhibiting effect
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438998A Quinolinyl and benzothiazolyc PPAR-gamma modulators
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438994A Polymorphic forms/hydrates of N-[4-(3-chloro-4-fluoro-phenylamino)-7- (3-morpholin-4-ylpropoxy)-quinazolin-6-Yl] acrylamide dihydrochloride
08/27/2003CN1438893A Therapeutical use of sophora flavescens or sophora subprostrated extracts
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438886A Ophthalmic solution
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438878A Topical pharmaceutical formulations and methods of treatment
08/27/2003CN1438873A Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
08/27/2003CN1438237A Echinocystic acid preparation methodÒÇümedicinal preparation and new use as medicine
08/27/2003CN1438236A Method for purifying Huanweihuangyangxing D and preparation thereof
08/27/2003CN1438018A Medicine for treating cerebrovascular accident and production method
08/27/2003CN1438014A Medicine for treating hypertension and preparation method
08/27/2003CN1438011A Compound Huangyangning (Chinese littleleaf box) small pills
08/27/2003CN1438008A Chinese medicine for treating pulmonary heart disease
08/27/2003CN1437997A Internal organs toxicant-eliminating pill and preparation method
08/27/2003CN1437993A Medicine for treating cerebrovascular accident and its sequel thereof
1 ... 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 ... 1595